These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 309728)
1. In vitro antibiotic synergism against ocular fungal isolates. Stern GA Am J Ophthalmol; 1978 Sep; 86(3):359-67. PubMed ID: 309728 [TBL] [Abstract][Full Text] [Related]
2. In vitro evaluation of combination antifungal activity against Fusarium species isolated from ocular tissues of keratomycosis patients. Li L; Wang Z; Li R; Luo S; Sun X Am J Ophthalmol; 2008 Nov; 146(5):724-8. PubMed ID: 18707669 [TBL] [Abstract][Full Text] [Related]
3. Rifampin Enhances the Activity of Amphotericin B against Fusarium solani Species Complex and Aspergillus flavus Species Complex Isolates from Keratitis Patients. He Y; Zhou L; Gao C; Han L; Xu Y Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28115342 [TBL] [Abstract][Full Text] [Related]
4. [Activity of butenafine against ocular pathogenic filamentous fungi in vitro]. Xu Y; Pang GR; Zhao DQ; Gao CW; Zhou LT; Sun ST; Wang BL; Chen ZJ Zhonghua Yan Ke Za Zhi; 2010 Jan; 46(1):38-42. PubMed ID: 20388321 [TBL] [Abstract][Full Text] [Related]
5. [The effect of propyl gallate on the activity of various antifungal drugs against filamentous fungi in vitro]. Xu Y; Pang GR; Lü XF; Chen ZJ; Sun ST; Song JZ Zhonghua Yan Ke Za Zhi; 2006 Apr; 42(4):309-12. PubMed ID: 16762206 [TBL] [Abstract][Full Text] [Related]
6. In vitro activity of thimerosal against ocular pathogenic fungi. Xu Y; Pang G; Zhao D; Gao C; Zhou L; Sun S; Wang B Antimicrob Agents Chemother; 2010 Jan; 54(1):536-9. PubMed ID: 19841144 [TBL] [Abstract][Full Text] [Related]
7. Natamycin and Azithromycin Are Synergistic Guo H; Zhou L; He Y; Gao C; Han L; Xu Y Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29735563 [TBL] [Abstract][Full Text] [Related]
8. Natamycin and Voriconazole Exhibit Synergistic Interactions with Nonantifungal Ophthalmic Agents against Rees CA; Bao R; Zegans ME; Cramer RA Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31010869 [TBL] [Abstract][Full Text] [Related]
9. In vitro activity of phenylmercuric acetate against ocular pathogenic fungi. Xu Y; Zhao D; Gao C; Zhou L; Pang G; Sun S J Antimicrob Chemother; 2012 Aug; 67(8):1941-4. PubMed ID: 22514262 [TBL] [Abstract][Full Text] [Related]
10. Amphotericin B and natamycin are not synergistic in vitro against Fusarium and Aspergillus spp. isolated from keratitis. Lalitha P; Shapiro BL; Loh AR; Fothergill AW; Prajna NV; Srinivasan M; Oldenburg CE; Quigley DA; Chidambaram JD; McLeod SD; Acharya NR; Lietman TM Br J Ophthalmol; 2011 May; 95(5):744-5. PubMed ID: 21030412 [No Abstract] [Full Text] [Related]
11. Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis. Lalitha P; Shapiro BL; Srinivasan M; Prajna NV; Acharya NR; Fothergill AW; Ruiz J; Chidambaram JD; Maxey KJ; Hong KC; McLeod SD; Lietman TM Arch Ophthalmol; 2007 Jun; 125(6):789-93. PubMed ID: 17562990 [TBL] [Abstract][Full Text] [Related]
12. Fungal strains and the development of tolerance against natamycin. Streekstra H; Verkennis AE; Jacobs R; Dekker A; Stark J; Dijksterhuis J Int J Food Microbiol; 2016 Dec; 238():15-22. PubMed ID: 27589020 [TBL] [Abstract][Full Text] [Related]
13. In vitro fungistatic and fungicidal activities of silver sulfadiazine and natamycin on pathogenic fungi isolated from horses with keratomycosis. Betbeze CM; Wu CC; Krohne SG; Stiles J Am J Vet Res; 2006 Oct; 67(10):1788-93. PubMed ID: 17014335 [TBL] [Abstract][Full Text] [Related]
14. In vitro synergisms obtained by amphotericin B and voriconazole associated with non-antifungal agents against Fusarium spp. Venturini TP; Rossato L; Spader TB; Tronco-Alves GR; Azevedo MI; Weiler CB; Santurio JM; Alves SH Diagn Microbiol Infect Dis; 2011 Oct; 71(2):126-30. PubMed ID: 21840673 [TBL] [Abstract][Full Text] [Related]
15. In vitro interactions between amphotericin B and other antifungal agents and rifampin against Fusarium spp. Spader TB; Venturini TP; Cavalheiro AS; Mahl CD; Mario DN; Lara VM; Santurio J; Alves SH Mycoses; 2011 Mar; 54(2):131-6. PubMed ID: 19780977 [TBL] [Abstract][Full Text] [Related]
16. Enhancement of the in vitro activity of amphotericin B against Aspergillus spp. by tetracycline analogs. Hughes CE; Harris C; Peterson LR; Gerding DN Antimicrob Agents Chemother; 1984 Dec; 26(6):837-40. PubMed ID: 6524900 [TBL] [Abstract][Full Text] [Related]
17. Is in vitro antibiotic combination more effective than single-drug therapy against anthrax? Athamna A; Athamna M; Nura A; Shlyakov E; Bast DJ; Farrell D; Rubinstein E Antimicrob Agents Chemother; 2005 Apr; 49(4):1323-5. PubMed ID: 15793105 [TBL] [Abstract][Full Text] [Related]
18. Virulence Attributes and Antifungal Susceptibility Profile of Opportunistic Fungi Isolated from Ophthalmic Infections. Sav H; Ozdemir HG; Altınbas R; Kiraz N; Ilkit M; Seyedmousavi S Mycopathologia; 2016 Oct; 181(9-10):653-61. PubMed ID: 27193295 [TBL] [Abstract][Full Text] [Related]
19. Synergistic action of amphotericin B and rifampin against Rhizopus species. Christenson JC; Shalit I; Welch DF; Guruswamy A; Marks MI Antimicrob Agents Chemother; 1987 Nov; 31(11):1775-8. PubMed ID: 3435124 [TBL] [Abstract][Full Text] [Related]
20. Correlation of in vitro and in vivo susceptibility of Candida albicans to amphotericin B and natamycin. O'Day DM; Ray WA; Robinson RD; Head WS Invest Ophthalmol Vis Sci; 1987 Mar; 28(3):596-603. PubMed ID: 3549613 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]